Literature DB >> 11603695

Cytokines in cartilage injury and repair.

M Lotz1.   

Abstract

Joint injury results in cartilage lesions that are characterized by a poor repair response, and such lesions often progress to osteoarthritis. Acute joint injury or chronic exposure of cartilage to an abnormal biochemical or biomechanical environment results in the activation of chondrocytes. This chondrocyte response is manifested by enhanced cell proliferation and death, matrix degradation, and new matrix synthesis. Cytokines are important stimuli of this chondrocyte activation response and trigger joint inflammation that can accompany cartilage injury. The presence of cytokines in cartilage is associated with abnormal extracellular matrix remodeling and loss, therefore defining them as a class of targets for therapeutic interventions. Insight into intracellular signaling mechanisms that are activated by cytokines may provide the basis for pharmacologic interventions that promote cartilage repair.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11603695     DOI: 10.1097/00003086-200110001-00011

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  66 in total

1.  Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscus.

Authors:  Amy L McNulty; J Brice Weinberg; Farshid Guilak
Journal:  Clin Orthop Relat Res       Date:  2008-10-31       Impact factor: 4.176

2.  Urinary levels of glycosaminoglycans in patients with idiopathic detrusor overactivity.

Authors:  Salvatore Siracusano; Antonio Cucchi; Stefano Ciciliato; Nicolitza Lampropoulou; Franco Vittur
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-08-12

3.  Scaffold structure and fabrication method affect proinflammatory milieu in three-dimensional-cultured chondrocytes.

Authors:  Heenam Kwon; Roshni S Rainbow; Lin Sun; Carrie K Hui; Dana M Cairns; Rucsanda C Preda; David L Kaplan; Li Zeng
Journal:  J Biomed Mater Res A       Date:  2014-05-03       Impact factor: 4.396

4.  Specific, Sensitive, and Stable Reporting of Human Mesenchymal Stromal Cell Chondrogenesis.

Authors:  Rodolfo E De la Vega; Maximiliano Scheu; Lennart A Brown; Christopher H Evans; Elisabeth Ferreira; Ryan M Porter
Journal:  Tissue Eng Part C Methods       Date:  2019-03       Impact factor: 3.056

5.  Genipin crosslinking decreases the mechanical wear and biochemical degradation of impacted cartilage in vitro.

Authors:  Craig M Bonitsky; Megan E McGann; Michael J Selep; Timothy C Ovaert; Stephen B Trippel; Diane R Wagner
Journal:  J Orthop Res       Date:  2016-09-19       Impact factor: 3.494

6.  Physiologic deformational loading does not counteract the catabolic effects of interleukin-1 in long-term culture of chondrocyte-seeded agarose constructs.

Authors:  Eric G Lima; Andrea R Tan; Timon Tai; Liming Bian; Gerard A Ateshian; James L Cook; Clark T Hung
Journal:  J Biomech       Date:  2008-09-26       Impact factor: 2.712

7.  Chondroprotective effects of glucosamine involving the p38 MAPK and Akt signaling pathways.

Authors:  Yi-Cheng Lin; Yu-Chih Liang; Ming-Thau Sheu; Yu-Chen Lin; Ming-Shium Hsieh; Tzeng-Fu Chen; Chien-Ho Chen
Journal:  Rheumatol Int       Date:  2008-03-14       Impact factor: 2.631

Review 8.  The influence of tissue microenvironment on stem cell-based cartilage repair.

Authors:  Chathuraka T Jayasuriya; Yupeng Chen; Wenguang Liu; Qian Chen
Journal:  Ann N Y Acad Sci       Date:  2016-07-27       Impact factor: 5.691

9.  MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses.

Authors:  Shigeru Miyaki; Tomoyuki Nakasa; Shuhei Otsuki; Shawn P Grogan; Reiji Higashiyama; Atsushi Inoue; Yoshio Kato; Tempei Sato; Martin K Lotz; Hiroshi Asahara
Journal:  Arthritis Rheum       Date:  2009-09

10.  The Intensive Diet and Exercise for Arthritis (IDEA) trial: design and rationale.

Authors:  Stephen P Messier; Claudine Legault; Shannon Mihalko; Gary D Miller; Richard F Loeser; Paul DeVita; Mary Lyles; Felix Eckstein; David J Hunter; Jeff D Williamson; Barbara J Nicklas
Journal:  BMC Musculoskelet Disord       Date:  2009-07-28       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.